75F40125F19001↗
CVS Healthspire Payor & Life Sciences LLC received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $1.38M obligated so far for special studies/analysis- medical/health. Its period of performance ended 2026-06-16.
Key facts · data as of Oct 22, 2026
- Recipient
- CVS Healthspire Payor & Life Sciences LLC
- Awarding agency
- Food and Drug Administration (Department of Health and Human Services)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Obligated to date
- $1.38M
- Potential value
- $1.38M
- Ends
- 2026-06-16
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 22, 2026.
Cite this page: SpendQuery, Award 75F40125F19001, data as of Oct 22, 2026, https://spendquery.com/award?id=CONT_AWD_75F40125F19001_7524_75F40124D00042_7524
CVS Healthspire Payor & Life Sciences LLC: all federal awards · Department of Health and Human Services: spending · Fda Office of Acq Grant Svcs: what it buys
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: HEALTH CARE DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS (BEST 3)
What it is
- Product or service
- Special Studies/Analysis- Medical/Health (PSC B537)
- Industry
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (NAICS 518210)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Competition
- Full and open competition · 2 offers received
- Pricing
- Time and materials
- How it was bought
- Multiple-award IDIQ · under 75F40124D00042
- Solicitation
- RFTOP-127381
- Where the work is
- Capitol, CT · district CT-01
- Topics
- cloud
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
3 actions since 2025-05-20. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-16 | P00002 | Close-out | -$4.0K | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FUNDS AND CLOSE OUT THE CONTRACT. |
| 2025-06-11 | P00001 | Administrative change | $0 | CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: HEALTH CARE DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS (BEST 3) - COMPANY NAME CHANGE |
| 2025-05-20 | 0 | $1.38M | CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: HEALTH CARE DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS (BEST 3) |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗